Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Saku, Väätäinen"'
Publikováno v:
Finnish Journal of eHealth and eWelfare, Vol 11, Iss 4 (2019)
HealthyWeighHub (HWH) is a 12-month coaching and education service designed to help patients with obesity make permanent life changes, launched and expanded gradually in Helsinki University Hospital (HUS) Healthvillage since 2016. We examined the
Externí odkaz:
https://doaj.org/article/dc6777345e894e9d8b6b812c10dec3ad
Autor:
Ilona Hallikainen, Janne Martikainen, Pei-Jung Lin, Joshua T. Cohen, Raquel Lahoz, Tarja Välimäki, Kristiina Hongisto, Saku Väätäinen, Matti Vanhanen, Peter J. Neumann, Tuomo Hänninen, Anne Maria Koivisto
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 4, Iss 3, Pp 494-508 (2014)
Background/Aims: Measuring and predicting Alzheimer's disease (AD) progression is important in order to adjust treatment and allocate care resources. We aimed to identify a combination of subtests from the Consortium to Establish a Registry for Alzhe
Externí odkaz:
https://doaj.org/article/b2631e81b79348df96b08f51a3ae8621
Autor:
Outi Virtanen, Erkki Soini, Saku Väätäinen, Kevin Bowrin, Jean-Baptiste Briere, Aurélie Millier
Publikováno v:
Advances in Therapy
Introduction Currently, 15–20% of individuals with coronary artery disease (chronic coronary syndrome [CCS]) or peripheral artery disease (PAD) receiving routine treatment experience cardiovascular events (CVEs) within 3–4 years. Using PICOSTEPS
Autor:
Saku Väätäinen, Henna Cederberg, Risto Roine, Sirkka Keinänen-Kiukaanniemi, Jouko Saramies, Hannu Uusitalo, Jaakko Tuomilehto, Janne Martikainen
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0147898 (2016)
OBJECTIVES:Present study examines the relationship between the estimated risk of developing type 2 diabetes (T2D) and health-related quality of life (HRQoL). We quantify the association between Finnish Diabetes Risk Score (FINDRISC) and HRQoL, and ex
Externí odkaz:
https://doaj.org/article/d9b629d3affe46b4a60aa9c686f6150e
Autor:
Julia Fiona-Maree Gilmartin, Saku Väätäinen, Soili Törmälehto, J Simon Bell, Eija Lönnroos, Lotta Salo, Ilona Hallikainen, Janne Martikainen, Anne M Koivisto, ALSOVA Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117926 (2015)
Neuropsychiatric symptoms of Alzheimer's disease (AD) such as depression may be associated with pain, which according to the literature may be inadequately recognized and managed in this population. This study aimed to identify the factors associated
Externí odkaz:
https://doaj.org/article/92f7ee66f5e54352920c0d80c23316ea
Publikováno v:
Advances in Therapy
Introduction There is an unmet need for well-tolerated antiepileptic drugs (AEDs) that effectively control focal onset seizures. This study aimed to evaluate the economic value of new AEDs in the treatment of focal onset seizure, with or without seco
Autor:
Thomas Hardt, Janne Martikainen, Erkki Soini, Saku Väätäinen, Wolfram Doehner, Ulrike Theidel
Publikováno v:
ESC Heart Failure. 4:274-281
Aims Treatment of iron deficiency (ID) in patients with heart failure (HF) with intravenous iron substitution [ferric carboxymaltose (FCM)] has previously shown significant improvements in exercise capacity, New York Heart Association (NYHA) function
Publikováno v:
Finnish Journal of eHealth and eWelfare, Vol 11, Iss 4 (2019)
Finnish Journal of eHealth and eWelfare
Finnish Journal of eHealth and eWelfare
HealthyWeighHub (HWH) is a 12-month coaching and education service designed to help patients with obesity make permanent life changes, launched and expanded gradually in Helsinki University Hospital (HUS) Healthvillage since 2016. We examined the dir
Autor:
Soili Törmälehto, Anne M. Koivisto, Janne Martikainen, Ilona Hallikainen, Jaana Suhonen, Sirpa Hartikainen, Tuomas Selander, Kristiina Hongisto, Tarja Välimäki, Saku Väätäinen
Publikováno v:
International Journal of Geriatric Psychiatry. 33:47-57
Objective To examine the association between neuropsychiatric symptoms (NPS) with self- and caregiver-rated Quality of Life (QoL) for patients with Alzheimer's disease (AD) during a 5-year follow-up. Methods The ALSOVA 5-year follow-up study included
Publikováno v:
Value in Health. 22:S630-S631